Moderna stock boosted after it announced its vaccine and after this, it was expected that the company’s stock would perform well. However, things did not go as smoothly as expected and the stock fluctuated a lot. The company’s stock faced ups and downs lately and this has made the decision of investing in Moderna stock quite speculative.

Moderna’s vaccine got approved by the Food and Drug Administration (FDA). It was developed and formulated using the messenger RNA (mRNA) technology and in this matter, the vaccine shares its similarity with the vaccine that Pfizer developed with its partner BioNTech and got it approved.

Moderna Inc. (NASDAQ: MRNA)

Moderna has claimed that its vaccine is 94.1% effective against the infection of the novel coronavirus. The vaccine has got approval and authorization in various countries around the world (more than 30). The company is making more and more doses of the vaccine as per the requirement of the same. 1.4 billion doses of this vaccine are expected in this year 2021 and could be more depending upon the demand of the vaccine. The final quarter revenue of Moderna has come out to be $571 million (in 2019, the fourth-quarter revenue was $14 million). The total annual revenue for the year 2020 was $803 million.

Moderna’s Latest Report on Statistics

  • 52 Week Range: $19.31 – $189.26
  • Average Volume: 18,759,237
  • Market Capital: $52.458B
  • Forward Dividend and Yield: N/A (N/A)

When is the Right Time to Invest in Moderna Stock?

Moderna has not had a very good performance in the past before it released its Covid-19 vaccine. The company got the real boost after the vaccine. It has grown greatly during the past year and we can see that from the 52 Week Range given above. The shares of the company have risen by as much as 434% and this percentage shows progress. The company is expected to do better in the upcoming future and analysts are positive about the same.

The coronavirus vaccine is in no doubt, a big reason as to why this firm has become so successful. However, now other companies are also coming up with their vaccines and if a more effective vaccine, comes up, then it would lessen the sale of Moderna’s vaccine. As of now, Moderna’s vaccine is amongst the leading vaccines and is expected to remain so.

The decision on whether to invest in the company’s stock right now is speculative. The investors should wait for now instead of going for an investment. Moderna needs to be observed and tracked for some time before investing. The future of the company looks bright and also profitable but it is always better to be completely sure about this. If the company makes good progress in the coming times also, then undoubtedly, it would make a great investment for the investors and would also bring in some fine profits.

Leave a Reply

Your email address will not be published.